Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Sepsis-induced neuromuscular dysfunction: A systematic review with meta-analysis.

Journal of infection and public health·2026
Same author

Impact of Immunoassay Selection on the sFlt-1/PlGF Ratio and Preeclampsia Risk Classification.

The journal of applied laboratory medicine·2026
Same author

Evaluation of the analytical performance and usability of the VChemy S analyzer for decentralized multipanel testing.

Diagnosis (Berlin, Germany)·2026
Same author

Holotranscobalamin-based algorithm for the identification of macro-vitamin B12 in analytical hypercobalaminemia.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

A Specimen-Based Comparative MicroCT-FEA Analysis of Vertebral Trabecular Bone Microarchitecture and Mechanical Response in Two South American Cervids: The Patagonian Huemul (<i>Hippocamelus bisulcus</i>) and the Southern Pudu (<i>Pudu puda</i>).

Biology·2026
Same author

Population Pharmacokinetics of Total and Free Ceftriaxone in Critically Ill and Non-Critically Ill Hospitalised Adult Patients.

International journal of antimicrobial agents·2026

相关实验视频

Updated: Sep 19, 2025

Ex Vivo Red Blood Cell Hemolysis Assay for the Evaluation of pH-responsive Endosomolytic Agents for Cytosolic Delivery of Biomacromolecular Drugs
11:12

Ex Vivo Red Blood Cell Hemolysis Assay for the Evaluation of pH-responsive Endosomolytic Agents for Cytosolic Delivery of Biomacromolecular Drugs

Published on: March 9, 2013

34.8K

常规数据分析中度血解干扰纠正在神经元特异性埃诺拉酶量化中.

Leyre Ruiz1, Tomás Munoz2, Alvaro González3,4

  • 1Service of Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain.

Biochemia medica
|June 16, 2025
PubMed
概括
此摘要是机器生成的。

一种新的配方可以纠正受中度血解影响的血清神经元特异性乙醇酶 (NSE) 水平. 这种方法使用对对的患者样本,减少了重复抽血的需要,并提高了神经内分泌瘤的诊断准确性.

关键词:
在NSE中,NSE是NSE,NSE是NSE.校正公式是一个校正公式.血液溶解 (hemolysis) 是一种干扰干扰是干扰的

更多相关视频

Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis
06:09

Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis

Published on: February 2, 2021

4.6K
Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
08:17

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

4.7K

相关实验视频

Last Updated: Sep 19, 2025

Ex Vivo Red Blood Cell Hemolysis Assay for the Evaluation of pH-responsive Endosomolytic Agents for Cytosolic Delivery of Biomacromolecular Drugs
11:12

Ex Vivo Red Blood Cell Hemolysis Assay for the Evaluation of pH-responsive Endosomolytic Agents for Cytosolic Delivery of Biomacromolecular Drugs

Published on: March 9, 2013

34.8K
Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis
06:09

Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis

Published on: February 2, 2021

4.6K
Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
08:17

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

4.7K

科学领域:

  • 临床化学 临床化学
  • 生物标记分析 生物标记分析
  • 实验室医学 实验室医学

背景情况:

  • 血清神经元特异性酶 (NSE) 是神经内分泌瘤和中枢神经系统损伤的关键生物标志物.
  • 红细胞相关的NSE可能会干扰由于血液溶解而导致的准确量化,这是血液样本处理中的一个常见问题.
  • 现有的治疗血液溶解的方法往往涉及人工样本操纵,这可能不反映真正的患者状况.

研究的目的:

  • 开发和验证一种新的正公式,用于通过中度*in vitro*血液溶解而受到影响的NSE血清度.
  • 建立一种使用配对,连续患者样本的方法,避免人工血液溶解剂兴奋剂.
  • 为了最大限度地减少由血液溶解引起的NSE测量中的临床偏差,从而可能避免样本重新绘制.

主要方法:

  • 在24小时内对患者样本进行回顾性分析,并对NSE和血解指数 (HI) 测量.
  • 使用开发队列 (N=41) 开发一个校正公式 (NSEcalc = NSE1 - (0.354 x (HI1 - HI2)) - 0.162).
  • 在单独的队列 (N=26) 上验证该公式,以评估修正后的NSE度 (NSEcalc).

主要成果:

  • 开发的配方显著降低了NSE测量中的偏差,校正值 (NSEcalc) 与非血液化样本没有显著差异 (NSE2,P = 0.291).
  • 未经纠正的血液溶解样本 (NSE1) 的中位相对偏差为22.5%,在84%的病例中超过了允许的误差极限.
  • 经过校正的值 (NSEcalc) 显示相对偏差降低了8.3%,只有23%超过了误差极限,与NSE2.2相比,偏差为-0.4μg/L.

结论:

  • 开发的校正公式为受中度血液溶解影响的血清NSE测量提供了临床显著的准确性.
  • 这种方法最大限度地减少了重复采集血液样本的需要,提高了实验室的效率和患者的便利性.
  • 该方法提供了一个潜在的框架,用于纠正其他生物标志物度易受"体外"血液溶解.